Source: Eur Respir J, 50 (6) 1701782; 10.1183/13993003.01782-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jean Bousquet, Guy Brusselle, Roland Buhl, William W. Busse, Alvaro A. Cruz, Ratko Djukanovic, Christian Domingo, Nicola A. Hanania, Marc Humbert, Andrew Menzies Gow, Wanda Phipatanakul, Ulrich Wahn, Michael E. Wechsler. Care pathways for the selection of a biologic in severe asthma. Eur Respir J, 50 (6) 1701782; 10.1183/13993003.01782-2017

Member's Comments

No comment yet.

Related content which might interest you: Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Investigating antioxidant therapy for steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 The frequency of exacerbations in COPD patients and its influence on the effects of pulmonary rehabilitation Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Montreal cognitive assessment in COPD Source: International Congress 2014 – Latest insights in chronic care Year: 2014 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Investigating the MCID of health status tools for patients with COPD in pulmonary rehabilitation Source: International Congress 2014 – Respiratory disease management in primary care Year: 2014 Do we treat different COPD patients depending on the guideline we use? Source: International Congress 2014 – Management of COPD in primary care Year: 2014 Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma Source: International Congress 2016 – Immune responses in the lung Year: 2016 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Comparison of the effects of two rehabilitation methods in COPD subjects Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Hospital care patterns in the management of acute exacerbated chronic obstructive pulmonary disease - A retrospective analysis from Zurich, Switzerland Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Identifying patients with severe allergic asthma who are potentially eligible for omalizumab treatment by EU licence and NICE guidance criteria Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 COPD patients' expectations of ICS/LABA therapy Source: International Congress 2014 – Management of COPD in primary care Year: 2014 Review on the clinical recognition and treatment of COPD exacerbations Source: Annual Congress 2012 - ERS/NEJM Lunchtime session "Advances in asthma and COPD" Year: 2012 Effect of experimental modulation of different mood states on dyspnea Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Paediatric severe asthma: a need for novel innate molecular phenotypes Source: Eur Respir J, 54 (2) 1901459; 10.1183/13993003.01459-2019 Year: 2019 Whether all general practice initiatives are effective in gaining asthma control in mild asthmatics? Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Use of a standardized order set in the management of an acute exacerbation of COPD Source: International Congress 2014 – Markers Year: 2014